Aug 2026· International Conference Computational Vision and Bio Inspired Computing· pp. 1184-1190· 0 citations· 24 references
Abstract
Accurate and timely prediction of in-Intensive-Care-Unit (ICU) mortality in stroke patients is essential for triage and resource allocation, yet the most accurate models reported on the Medical Information Mart for Intensive Care IV (MIMIC-IV) database are large ensembles or gradient-boosted trees whose memory footprint and inference cost hinder deployment at the bedside. In this work, a compression-first knowledge distillation (KD) framework is proposed in which an ensemble of three Transformer teachers transfers dark knowledge to a 1,633-parameter multilayer-perceptron student through a temperaturecorrected logit-matching objective augmented with FitNets-style feature hints. A stroke cohort of 12,408 ICU admissions was extracted from MIMIC-IV and processed with leakage-controlled Multiple Imputation by Chained Equations and patient-level splitting. On a held-out test set of 1,862 patients, the distilled student attains an AUROC of 0.931 (95% CI [0.914, 0.948]), which is statistically indistinguishable from the Transformer ensemble, XGBoost, LightGBM and Random Forest under the DeLong test ($p>0.28$ in all cases), while being $171 \times$ smaller than a single teacher and $2,939 \times$ smaller and $876 \times$ faster than the strongest tree baseline. A multi-seed capacity sweep and a 50-configuration hyperparameter analysis are reported to delineate the regime in which distillation contributes measurable value. The results demonstrate that bedside-deployable mortality scoring is achievable without sacrificing discriminative performance, and that rigorous statistical validation is indispensable when reporting marginal differences on clinical prediction tasks.
Background: PADS combines two neural networks predicting ICU mortality and discharge within 48 h, placing critically ill patients into one of four clinically meaningful states. Developed on MIMIC-IV alone, it left open whether it generalizes to other ICUs, whether its models transfer across hospitals, and whether its p...
Àlex Pardo, J. Gómez, J. Berrueta et al.· Journal of Clinical Medicine· 0 citations
Sepsis and heart failure share early-warning physiology but require divergent treatments, complicating early intensive care intervention. Current predictive models address these conditions independently. We present DualStream-MTCA, a hybrid deep-learning architecture for the simultaneous early detection of both conditi...
MultiCardioNet, a multimodal deep learning framework for early prediction of a composite ICU deterioration endpoint using MIMIC-IV data, suggests that the three modalities provide complementary information for this composite deterioration endpoint in the internal test setting.
Bassem Jandoubi, M. Akhloufi· Bioengineering· 0 citations
Predicting sepsis mortality in the ICU is a challenging and complex clinical AI problem. Although there is enough data available, the most statistically significant information is hidden within time-based trajectories that most published models ignore. In the earlier research based on SMOTE RF RFE XGBoost pipeline for...
Aparna Bhonde, N. Thakur, Jyoti Baviskar· International Conference on...· 0 citations
It is argued that LASSO, not the highest-discriminating model, is the model best suited to direct clinical deployment, and lessons for the machine learning and healthcare community regarding data infrastructure, model selection, and value of calibration and interpretability in high-stakes decision support are presented...
Asra Aslam, Volodymyr Chapman, M. O'Connell et al.· 0 citations
Sepsis continues to be a major cause of death in ICUs, with 48.9 million cases and about 11 million deaths being registered each year. However, while early detection is crucial, methods like SIRS criteria and SOFA score always seem to fail to identify sepsis before severe organ dysfunction sets in. This research sugges...
D. Srivastava· Natural Resources for Human...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.